Title:
涙道チューブ
Document Type and Number:
Japanese Patent JP7169104
Kind Code:
B2
Abstract:
To provide a lacrimal duct tube in which a high effect of treatment of a lacrimal duct can be obtained, and re-occlusion can be prevented.SOLUTION: A lacrimal duct tube concerning the present invention has an anti-inflammatory or an epithelial cell growth promoting agent arranged in at least a portion. Preferably, the anti-inflammatory or the epithelial cell growth promoting agent may be a rebamipide or an analog. Also, it is preferable that the anti-inflammatory or the epithelial cell growth promoting agent may be arranged in the inside of the lacrimal duct tube. Further, it is preferable that the lacrimal duct tube may include a bougie hole, and the anti-inflammatory or the epithelial cell growth promoting agent may be arranged at the side opposite to the bougie insertion direction to the bougie hole and in the inside of the lacrimal duct tube.SELECTED DRAWING: Figure 1
More Like This:
| WO/2023/172585 | METHOD AND SYSTEM FOR DELIVERY OF THERAPEUTICS TO EYE |
| JP2022519133 | Transplant device |
| WO/2023/045918 | INTRAOCULAR RULER |
Inventors:
Kohei Fukaya
Masashi Mimura
Masashi Mimura
Application Number:
JP2018128133A
Publication Date:
November 10, 2022
Filing Date:
July 05, 2018
Export Citation:
Assignee:
Kaneka Corporation
Daikyo Health Development Co., Ltd.
Daikyo Health Development Co., Ltd.
International Classes:
A61F9/007; A61K9/02; A61K31/4704; A61K47/34; A61L31/10; A61L31/14; A61L31/16; A61P27/02
Domestic Patent References:
| JP9276318A | ||||
| JP9301866A | ||||
| JP2015013121A | ||||
| JP200513698A |
Foreign References:
| US20170128266 |
Attorney, Agent or Firm:
Yuichi Niiyama